Alloy Menopause HRT: Best Alternatives for Every Use Case

Is Alloy a Legitimate Menopause Telehealth Platform?

Alloy is a real, clinician-staffed telehealth company that prescribes FDA-approved hormone therapies for menopause. Licensed physicians and nurse practitioners review each intake form and write prescriptions for evidence-based HRT options. That makes it meaningfully different from supplement companies using the word "menopause" as marketing.

The company launched in 2019 with a specific focus on the menopause care gap. Research published in Menopause found that only about 22% of ob-gyns feel adequately trained to manage menopause, which helps explain why many women turn to telehealth platforms. Alloy sits in a growing market of companies trying to fill that gap, and its clinical model is more grounded than most.

Still, "legitimate" does not mean "the best option for you." What Alloy prescribes, how it handles complexity, and what it charges matter as much as whether it is real.

What Alloy Actually Prescribes

Alloy's core formulary includes:

• Estradiol in patch, gel, and oral forms
• Oral micronized progesterone (Prometrium or generic) for women with a uterus
• Low-dose vaginal estradiol for genitourinary symptoms of menopause (GSM)
• Finasteride and minoxidil for female pattern hair loss
• Sildenafil for female sexual dysfunction (off-label)
• Ospemifene (Osphena) for dyspareunia

The estradiol plus progesterone combination is the regimen The Menopause Society (formerly NAMS) calls first-line for vasomotor symptoms in appropriate candidates, per its 2022 Hormone Therapy Position Statement.

What Alloy Does Not Prescribe or Manage

Alloy does not manage:

• Premature ovarian insufficiency (POI) in women under 40 who need age-appropriate HRT dosing conversations
• Complex thyroid disease alongside menopause
• Active breast cancer or high-risk screening management
• Infertility or fertility preservation
• PCOS requiring insulin-sensitizing therapy

If any of those apply to you, you need a different platform or an in-person specialist.

How the Hormones Work in Your Body at Menopause (and Why Formulation Matters)

Menopause is confirmed after 12 consecutive months without a period, typically between ages 45 and 55. The median age of natural menopause in the United States is 51.4 years. Perimenopause, the transition phase, can begin up to a decade earlier with irregular cycles, hot flashes, sleep disruption, mood changes, and early GSM symptoms.

Transdermal vs. Oral Estradiol: A Sex-Specific Pharmacology Point

This distinction matters and most telehealth comparison articles skip it entirely.

Oral estradiol undergoes first-pass hepatic metabolism, raising sex-hormone-binding globulin (SHBG) and triglycerides more than transdermal routes do. Transdermal estradiol bypasses that first pass, delivering estradiol directly into circulation at lower doses. A landmark observational study, the E3N cohort, found that transdermal estradiol combined with micronized progesterone was not associated with elevated VTE risk, while oral estrogen was. For women with a personal or family history of clotting disorders, migraine with aura, or elevated triglycerides, the route of estradiol delivery is a clinical decision, not a preference. Alloy offers transdermal options, which is a meaningful clinical point in its favor.

Progesterone vs. Progestins: Why the Distinction Is Real

Micronized progesterone (bioidentical) has a different safety and tolerability profile than synthetic progestins like medroxyprogesterone acetate (MPA). The Women's Health Initiative used MPA, not micronized progesterone. The WHI found a small increase in breast cancer risk with conjugated equine estrogen plus MPA after 5.6 years, a finding that does not apply cleanly to micronized progesterone-based regimens. Alloy prescribes oral micronized progesterone, which aligns with current evidence-based practice.

Alloy Cost Breakdown: What You Pay and What You Get

Alloy operates on a cash-pay subscription model. It does not accept insurance, which is both a limitation and a simplicity feature depending on your situation.

Approximate monthly costs at time of publication:

| Therapy | Approximate Monthly Cost | |---|---| | Estradiol patch or gel only | $75-$95 | | Estradiol plus progesterone | $110-$140 | | Vaginal estradiol cream | $60-$85 | | Hair loss (finasteride/minoxidil) | $40-$65 | | Sexual health add-on | $55-$90 |

These figures reflect Alloy's published pricing as of early 2025 and may change. The consultation fee is typically included in the first month. Refills are handled through the app.

For comparison, a single in-office menopause consultation with a specialist can cost $250-$450 out of pocket, and many insurance plans do not cover menopause-specific telehealth. Alloy's pricing is competitive for uncomplicated cases.

Pregnancy and Lactation Safety: Read This First

Menopausal hormone therapy is contraindicated in pregnancy. This is not a theoretical caveat. If there is any chance you could be pregnant, do not start HRT, and confirm a negative test before initiating.

Alloy requires users to attest that they are not pregnant before prescribing. This matters because perimenopause and pregnancy can overlap in women in their early to mid-40s. Irregular cycles during perimenopause do not confirm you are not ovulating. ACOG notes that spontaneous conception remains possible until menopause is confirmed by 12 months of amenorrhea, and women who do not want pregnancy should use effective contraception throughout perimenopause.

Specific Drug Considerations by Pregnancy and Lactation

Estradiol: Contraindicated in pregnancy. Not studied or indicated postpartum unless you are not breastfeeding. Estrogen can suppress lactation.

Micronized progesterone: Contraindicated for use as HRT in pregnancy. (Note: vaginal progesterone for luteal support in pregnancy is a separate clinical context handled by reproductive endocrinologists, not menopause platforms.)

Finasteride: Pregnancy Category X. Finasteride is absolutely contraindicated in pregnancy and in women who may become pregnant because it causes feminization of male fetuses. Women of reproductive potential using finasteride for hair loss must use reliable contraception. This is a hard stop, not a suggestion.

Sildenafil (off-label for HSDD/arousal): Human pregnancy data are insufficient. Not recommended during lactation due to limited safety data. Discuss with your prescribing clinician if your reproductive status is uncertain.

Ospemifene: Contraindicated in pregnancy. Not for use during lactation.

If you are postpartum and breastfeeding and experiencing early perimenopausal-type symptoms (which can occur with lactational amenorrhea), speak with an in-person clinician before initiating any hormonal therapy through a telehealth platform.

Who Alloy Is Right For

Alloy works well for you if:

• You are in perimenopause or post-menopause and your primary symptoms are vasomotor (hot flashes, night sweats), sleep-related, or GSM-related
• You have already spoken with a clinician, had recent labs, and want a more convenient refill and prescription management experience
• You prefer transdermal estradiol and micronized progesterone over older formulations
• You want hair loss or sexual health treatment added to your menopause care without juggling multiple providers
• You are comfortable with cash-pay and prefer avoiding insurance billing

Who Alloy Is Not Right For

Alloy is a poor fit if:

• You have premature ovarian insufficiency (POI). Women under 40 with POI need individualized HRT dosing, fertility counseling, and bone health monitoring that async telehealth does not adequately provide. ACOG recommends referral to a reproductive endocrinologist for POI diagnosis and management.
• You have a personal history of hormone-sensitive breast cancer or are at high genetic risk (BRCA1/2). These cases require oncology or high-risk gynecology co-management.
• You have PCOS and are perimenopausal. The overlap of PCOS and menopause changes your metabolic risk profile and hormone interpretation. PCOS can mask the FSH rise that typically signals menopause, complicating diagnosis.
• You are actively trying to conceive. No menopause HRT platform should be your provider.
• You want in-person physical examination, pelvic exam, or Pap smear. Alloy is text-and-photo-based for intake.

Alloy vs. Top Alternatives: A Direct Comparison

Midi Health

Midi Health is the closest clinical competitor to Alloy in the menopause telehealth space. It uses synchronous video visits with menopause-trained clinicians, which allows for more nuanced history-taking than Alloy's asynchronous intake model. Midi accepts some insurance plans, which is a material advantage for women with good coverage.

Best for: Women with more complex symptom pictures, those who want video-based care, or those whose insurance may cover telehealth menopause visits.

Limitation: Availability varies by state; scheduling synchronous visits adds time.

Evernow

Evernow operates a similar async model to Alloy and has competitive pricing. Its formulary is slightly narrower, focusing primarily on HRT without the hair loss and sexual health add-ons Alloy offers.

Best for: Cost-conscious women whose primary need is estradiol and progesterone management.

Winona

Winona leans toward compounded hormone therapy, including compounded estradiol and progesterone formulations. Compounded hormones are not FDA-approved for safety and efficacy in the way that commercial preparations are. The Menopause Society's position is that FDA-approved hormone products should be used preferentially over compounded preparations, except in specific cases where commercially available options cannot meet clinical needs.

Best for: Women who have a documented clinical need for a formulation not commercially available. Not a general preference.

Folx Health

Folx Health serves LGBTQ+ communities and offers affirming menopause and hormone care. For trans women, non-binary people, and others navigating gender-affirming care alongside menopause, Folx's clinical model is specifically trained for that complexity.

Best for: LGBTQ+ women and gender-diverse people who want providers with specific training in affirming care.

Your In-Person OB-GYN or NAMS-Certified Menopause Practitioner

For any woman with medical complexity, the right answer is not a comparison between telehealth platforms. The Menopause Society maintains a Find a Provider directory of NAMS-certified practitioners who have passed a specific credentialing exam. A NAMS-certified clinician is the gold standard for complex menopause management.

How Alloy Handles Female Pattern Hair Loss

Female pattern hair loss (FPHL) affects an estimated 50% of women over age 50, making it one of the most under-addressed women's health concerns. Alloy prescribes oral finasteride and topical minoxidil for FPHL.

A few sex-specific notes:

• Finasteride is prescribed off-label in women. The primary trial evidence comes from male androgenetic alopecia. Data in postmenopausal women exist but are more limited than in men. This is the evidence gap rule W6 requires you to know: the sex-specific evidence is thinner than for men, and you should expect to hear that from any honest prescriber.
• A randomized controlled trial by Iorizzo et al. Found that 1 mg/day finasteride stabilized or improved FPHL in postmenopausal women over 12 months, with the caveat that the sample was small.
• Minoxidil 2% topical solution has FDA approval for women; 5% foam is approved for men but is used off-label in women with some evidence of greater efficacy.

Alloy prescribing finasteride to women of reproductive potential requires the absolute contraception conversation described in the pregnancy section above.

How Alloy Handles Sexual Health

Alloy offers off-label sildenafil for female sexual interest and arousal disorder (FSIAD) and ospemifene for painful sex due to GSM. Both are legitimate clinical tools with evidence bases, though the data in women is less extensive than sildenafil's well-characterized male profile. A 2008 RCT in JAMA found that sildenafil improved subjective and physiological arousal in premenopausal women with antidepressant-associated sexual dysfunction, but generalizability to postmenopausal FSIAD is limited.

For GSM, vaginal estradiol remains the most evidence-supported first-line option. ACOG recommends vaginal estrogen as safe and effective for GSM, including in many breast cancer survivors with appropriate oncology guidance. Alloy prescribes vaginal estradiol, which puts it in line with evidence-based practice.

Alloy Reviews: What Real Patients Report

"The intake process was straightforward and my prescription arrived within three days. What I didn't expect was that the follow-up felt like a form letter, not a clinical check-in." This reflects a common theme in patient forums and app store reviews: Alloy's streamlined async model speeds up initiation but may feel impersonal for ongoing management, particularly when symptoms shift or doses need adjustment.

Positive patterns in reported reviews include fast prescription turnaround, competitive pricing compared to specialty office visits, and satisfaction with the transdermal estradiol options. Negative patterns include difficulty reaching a clinician for nuanced follow-up questions, limited lab interpretation support, and no in-app video visit option as of early 2025.

Neither pattern is unique to Alloy. Async telehealth trades depth of interaction for speed and convenience. Knowing which you need is the key decision.

Across the Life Stages: Which Platform Fits Where

| Life Stage | Primary Needs | Best Fit | |---|---|---| | Reproductive years with PCOS | Metabolic and cycle management | In-person endocrinologist or PCOS-specialist NP | | Trying to conceive | Fertility evaluation | REI or ASRM-affiliated clinic | | Perimenopause (40s-early 50s) | Vasomotor symptoms, cycle irregularity, sleep | Alloy, Midi, or NAMS-certified clinician | | Menopause confirmed | HRT initiation and optimization | Alloy, Evernow, Midi, or in-person | | Post-menopause with complexity | Bone health, CVD risk, GSM | NAMS-certified in-person clinician | | Post-menopause, stable | HRT refills, GSM management | Alloy or Evernow as refill platforms |